Deepak Cyril D’Souza

Yale University — United States

Medicine · Health Sciences

60h-index13.2kcitations245works7.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cannabis and Cannabinoid Research(94), Neuroscience and Neuropharmacology Research(61), Neurotransmitter Receptor Influence on Behavior(55), Tryptophan and brain disorders(39), Treatment of Major Depression(38)

Publications243 total

Cannabis, Aging and Cognition: An Urgent Need for Research
Cannabis and Cannabinoid Research·2025
Optimized reference region and the effect on test-retest reliability and detection of Parkinson’s disease with [ <sup>11</sup> C]UCB-J
2025Open Access
A Preliminary Investigation of Brain Cannabinoid Receptor Type 1 (CB1R) Availability in Men with Opioid Use Disorder
2025Open Access
Cannabinoid 1 receptor availability in posttraumatic stress disorder: A positron emission tomography study
Translational Psychiatry·2025· 1 citedOpen Access
Interactions of alcohol and the benzodiazepine inverse agonist in healthy male volunteers
Journal of Psychopharmacology·2025
Cannabinoid Receptor Type 1 Availability in Individuals with a History of Childhood Trauma: A Positron Emission Tomography Study
2025Open Access
Opposing Modulation of EEG Aperiodic Component by Ketamine and Thiopental: Implications for the Noninvasive Assessment of Cortical E/I Balance in Humans
2025· 2 citedOpen Access
Psilocybin’s Effects on Headache Frequency are Not Related to Acute Psychedelic Effects or Measures of Mental Health: Secondary Analysis of Clinical Trials in Migraine and Cluster Headache (P7-12.001)
Neurology·2025
Generating synthetic brain PET images of synaptic density based on MR T1 images using deep learning
EJNMMI Physics·2025· 4 citedOpen Access
To Hear or Not to Hear: Cognitive Load Theory and Learning
Qapsule Queen s Undergraduate Health Sciences Journal·2024Open Access
Endocannabinoid Signaling and Food Addiction
2024
Behavioral, Cognitive and Electrophysiological Presentation and Short-Term Course of Cannabis Related First Episode Psychosis
Biological Psychiatry·2024
37. The Structural Connectome Constrains in Vivo Synaptic Density Loss in Schizophrenia
Biological Psychiatry·2024
Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial
Scientific Reports·2024· 46 citedOpen Access
Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial
Journal of the Neurological Sciences·2024· 29 cited
Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile
Biological Psychiatry Cognitive Neuroscience and Neuroimaging·2024· 43 citedOpen Access
Psychopharmacological Treatment of Schizophrenia
Elsevier eBooks·2024
The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [11C]UCB-J
European Journal of Nuclear Medicine and Molecular Imaging·2023· 22 citedOpen Access
Dysregulation of the endogenous cannabinoid system following opioid exposure
Psychiatry Research·2023· 6 citedOpen Access
Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms
Journal of Psychopharmacology·2023· 44 cited
page 1 of 13Next →

Frequent Co-authors

John H. Krystal(19), Mohini Ranganathan(19), Brian Pittman(11), Ralitza Gueorguieva(9), Rajiv Radhakrishnan(9), Edward Perry(8), Patrick D. Skosnik(8), Anissa Abi‐Dargham(7), Ismene L. Petrakis(6), R. Andrew Sewell(6), Thomas B. Cooper(5), Gabriel Braley(5), Yiyun Huang(5), Richard E. Carson(5), Mohamed Sherif(5), Naomi Driesen(4), Toral Surti(4), Ashley M. Schnakenberg Martin(4), Halle Thurnauer(4), Jose Cortes-Briones(4)